Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07102888
PHASE2
A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
View on ClinicalTrials.gov
Summary
This study is to evaluate the safety, tolerability, pharmacokinetics and efficacy of RSS0393 topical ointment in the treatment of plaque psoriasis in children and adolescents.
Official title: A Phase II Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
Key Details
Gender
All
Age Range
6 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-08
Completion Date
2026-02
Last Updated
2025-08-05
Healthy Volunteers
No
Interventions
DRUG
RSS0393 Ointment
RSS0393 ointment.
Locations (1)
Beijing Children's Hospital, Capital Medical University
Beijing, Beijing Municipality, China